InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the complete record of transactions filed by Willoughby Scott B., SVP, Conseiller Général et Secrétaire. Director active across 1 company, notably Sangamo Therapeutics, INC. Aggregated, 28 disclosures have been recorded. History available since 13 August 2021. The latest transaction was disclosed on 24 February 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Willoughby Scott B.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报28 总计
1,650 股@ US$0.47250.2% 占其流量Common StockSEC:0001877368-26-000004:0
36,676 股@ US$0.39854.6% 占其流量Common StockSEC:0001877368-26-000002:0
2,035 股@ US$0.41660.3% 占其流量Common StockSEC:0001877368-25-000007:0
44,122 股@ US$0.669.8% 占其流量Common StockSEC:0001877368-25-000005:0
1,434 股@ US$0.58630.3% 占其流量Common StockSEC:0001415889-25-023077:0
31,866 股@ US$0.47985.6% 占其流量Common StockSEC:0001415889-25-020244:0
1,433 股@ US$0.47330.2% 占其流量Common StockSEC:0001415889-25-014695:0
31,866 股@ US$0.77639.9% 占其流量Common StockSEC:0001415889-25-011287:0
1,434 股@ US$1.000.6% 占其流量Common StockSEC:0001415889-25-005706:0
129,549 股@ US$1.1565.3% 占其流量Common StockSEC:0001415889-25-002021:0
1,430 股@ US$1.881.2% 占其流量Common StockSEC:0001415889-24-027705:0
1,430 股@ US$0.860.5% 占其流量Common StockSEC:0001415889-24-022312:0
892 股@ US$0.97510.4% 占其流量Common StockSEC:0001415889-24-021365:0
1,400 股@ US$0.600.4% 占其流量Common StockSEC:0001415889-24-014796:0
4,379 股@ US$1.132.1% 占其流量Common StockSEC:0001415889-24-005550:0
712,500 股0Common StockSEC:0001415889-24-001757:0
1,329 股@ US$0.38210.2% 占其流量Common StockSEC:0001209191-23-056791:0
1,329 股@ US$0.770.4% 占其流量Common StockSEC:0001209191-23-047577:0
864 股@ US$1.080.4% 占其流量Common StockSEC:0001209191-23-045879:0
1,328 股@ US$1.330.8% 占其流量Common StockSEC:0001209191-23-032914:0
3,977 股@ US$1.652.7% 占其流量Common StockSEC:0001209191-23-025721:0
42,750 股0Common StockSEC:0001209191-23-016399:0
864 股@ US$6.332.4% 占其流量Common StockSEC:0001209191-22-046022:0
140 股@ US$4.150.2% 占其流量Common StockSEC:0001209191-22-026801:0
3,976 股@ US$4.706.4% 占其流量Common StockSEC:0001209191-22-025671:0
28 条申报中的 25 条
About Willoughby Scott B.
Willoughby Scott B. is SVP, Conseiller Général et Secrétaire at Sangamo Therapeutics, INC. He has 28 filings in total, and across the recent sampled filings, the most frequent transaction nature is Retenue fiscale, with a period spanning 2021-08-17 to 2026-02-26.
